Cellosaurus Sup-T1 Nef-ER 31 (CVCL_1H35)
Cell line name | Sup-T1 Nef-ER 31 |
---|---|
Synonyms | Nef-ER 31; Nef-ER #31; Nef-ER #31 Clone; Nef-ER Expressing Sup-T1 Cells (Clone 31) |
Accession | CVCL_1H35 |
Resource Identification Initiative | To cite this cell line use: Sup-T1 Nef-ER 31 (RRID:CVCL_1H35) |
Comments | Population: Caucasian. Characteristics: Expresses a chimeric Nef-estrogen receptor hormone-binding domain (Nef-ER) protein. Nef-ER is kept in an inactive state due to steric hindrance, and addition of the membrane-permeable drug 4-hydroxytamoxifen (4-HT), which binds to the ER domain, leads to inducible activation of Nef-ER within cells (PubMed=11134296). Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1352467; Esr1 (Note=With p.Met1_Asp484del and p.Ile486_Ile599del). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q90VU7; HIV-1 isolate NL4-3 nef. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Cell type: T-cell; CL=CL_0000084. |
Sequence variations |
|
Disease | Childhood T lymphoblastic lymphoma (NCIt: C7210) T-cell non-Hodgkin lymphoma (ORDO: Orphanet_171918) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1714 (SUP-T1) |
Sex of cell | Male |
Age at sampling | 8Y |
Category | Cancer cell line |
Publications | PubMed=11134296; DOI=10.1128/JVI.75.2.834-843.2001; PMCID=PMC113979 |
Cross-references | |
Cell line collections (Providers) | BEI_Resources; ARP-6453 |
Cell line databases/resources | cancercelllines; CVCL_1H35 |
Encyclopedic resources | Wikidata; Q54930388 |
Entry history | |
Entry creation | 08-Jul-2015 |
Last entry update | 19-Dec-2024 |
Version number | 16 |